[Ophthalmologic treatment of Behcet's syndrome].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000188:drug therapy*; D002386:Cataract / Q000209:etiology / Q000628:therapy; D003888:Desensitization, Immunologic; D005132:Eye Manifestations; D005901:Glaucoma / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009184:Mydriatics; D013256:Steroids / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D009184:Mydriatics; D013256:Steroids